Suppr超能文献

接受玻璃体切除术治疗增殖性糖尿病视网膜病变患者的长期生存率

Long-Term Survival Rates of Patients Undergoing Vitrectomy for Proliferative Diabetic Retinopathy.

作者信息

Banerjee Philip J, Moya Rene, Bunce Catey, Charteris David G, Yorston David, Wickham Louisa

机构信息

a Moorfields Eye Hospital , London , UK.

b Fundación Oftalmológica Los Andes , Santiago , Chile.

出版信息

Ophthalmic Epidemiol. 2016;23(2):94-8. doi: 10.3109/09286586.2015.1089578. Epub 2016 Mar 8.

Abstract

PURPOSE

Reported 5-year survival rates in patients undergoing vitreous surgery for proliferative diabetic retinopathy (PDR) range from 68-95%. Studies relating survival rates to medical baseline characteristics predate the millennium. This study aimed to update data on life expectancy of patients undergoing vitrectomy for PDR and identify baseline factors which may influence survival.

METHODS

A retrospective cohort study of consecutive patients who underwent their first pars-plana vitrectomy for PDR between April 2004 and May 2005 was performed. Survival status on 1 May 2012 was the primary endpoint. The Kaplan-Meier life table method was used to determine survival rates. Univariate and multiple variable Cox proportional hazards regressions were used to identify risk factors for mortality.

RESULTS

A total of 148 patients were included in the study, with a mean age of 54 years (range 20-80 years) at time of surgery. The 3-, 5- and 7-year survival rates were 94%, 86% and 77%, respectively (95% confidence interval, CI, 88-97%, 79-91% and 68-84%, respectively). Renal failure was the most common cause of death. The presence of limb ulcers at baseline was the most important prognostic indicator for mortality, with a hazard ratio of 3.13 (95% CI 1.46-6.71, p = 0.003) and a survival rate at 5 years reduced to 79%.

CONCLUSION

The 5-year survival rate remains comparable to those reported 20 years ago despite a lowering in threshold for vitrectomy and increased health awareness. Limb ulcers are strongly associated with increasing mortality. Clinicians should remain mindful of the systemic associations of diabetes particularly in advanced retinal disease.

摘要

目的

接受玻璃体手术治疗增殖性糖尿病视网膜病变(PDR)的患者报告的5年生存率在68%至95%之间。将生存率与医学基线特征相关联的研究早于千禧年。本研究旨在更新接受PDR玻璃体切除术患者的预期寿命数据,并确定可能影响生存的基线因素。

方法

对2004年4月至2005年5月期间连续接受首次PDR扁平部玻璃体切除术的患者进行回顾性队列研究。2012年5月1日的生存状态是主要终点。采用Kaplan-Meier生命表法确定生存率。单变量和多变量Cox比例风险回归用于识别死亡风险因素。

结果

共有148例患者纳入研究,手术时平均年龄为54岁(范围20 - 80岁)。3年、5年和7年生存率分别为94%、86%和77%(95%置信区间,CI,分别为88 - 97%、79 - 91%和68 - 84%)。肾衰竭是最常见的死亡原因。基线时存在肢体溃疡是死亡的最重要预后指标,风险比为3.13(95% CI 1.46 - 6.71,p = 0.003),5年生存率降至79%。

结论

尽管玻璃体切除术的阈值降低且健康意识提高,但5年生存率仍与20年前报告的相当。肢体溃疡与死亡率增加密切相关。临床医生应始终关注糖尿病的全身关联,尤其是在晚期视网膜疾病中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验